Stock Market Graph

Search Results


What to Watch Week of February 8th, 2021

I do live trading on my Twitter and would like to post the real option trades that I am doing, and what my current watchlist is. Follow along on my journey to $1 million. 1-on-1 Private Coaching via Zoom is now available. Whether it is portfolio building and review, formulating a personalized options strategy, or the basics of how to trade - I'll make your portfolio relevant. Email me here or DM me via social media.


YouTube Video Link: HERE


New Discord Server is Live: Join Now

Due to the high volume of questions that I am getting, I will be prioritizing answering all questions in the VIP section of this server.


Overall, last week was pretty boring. Most notably semiconductors pulled back and are at good buying levels right now. My $SMH call is down and I'm thinking of buying more. The beginning of last week provided a decent buying opportunity overall ,but pretty flat towards the end. As most of you know, trading flat is not good for options because of the decay. This is why we keep diversified and small positions. If you only trade options, you will be hurt sooner or later.

$LI is still bouncing on my support and in my buy zone. I will also be looking toward $AAPL to possibly pick up some $180 strike LEAPS - you can also consider some cheaper credit spreads.

For more information on price targets, entry, risk, and timeframe, see the official watchlist.


Adding to the Watchlist:

$CNCE: Concert Pharmaceuticals, Inc. is a clinical stage biotechnology company. The Company focuses on the use of deuterium to enhance the effects of approved drugs. Concert Pharmaceuticals offers its products throughout the United States. Last week prices plunged after a disappointing test result on schizophrenia test result came out. Overall, I see this as a chance to pick up cheap shares, of course it doesn't come without risks. This one test result isn't end game for this company.

  • Target Price: $15

  • Entry: <$7

  • Risk: 5

  • Timeframe: 2-4 months


$ELY: Callaway is a company that produces golf products such as clubs. The overall consensus is that the golf consumer market will continue to grow in the next 5-10 years. Therefore, I will classify $ELY as a underrated growth stock. Currently it is more expensive than I'd like to pay, as I always try to get cheap entries, so I'll be waiting for this one to correct.

  • Target Price: $35

  • Entry: <$26

  • Risk: 3

  • Timeframe: 3-5 months


$MVIS: Microvision is a developer of laser beam scanning technology. If you haven't realized yet that this type of tech is only going to grow more prevalent in the future, then your portfolio will be stuck in the past. The growth forecast for this industry is going to be huge. If you would like to take a deeper dive into this stock, I'd suggest looking over the "news" tab in Webull. There is so much FA that we can perform. As you can see from the chart, $MVIS has run up quite a bit last week. I will be anxiously anticipating a small correction. My target is around $15 so there isn't much room since it is trading at $11.54 market close Friday. If it pulls back, I believe its a winner and the risk is minimized somewhat.

  • Target Price: $15

  • Entry: <$9

  • Risk: 5

  • Timeframe: 2-4 months


Keep in mind, the official watchlist is updated weekly and I will continually watch for entries on those tickers.


Note: Risk (1 out of 5) is my opinion of how risky the stock and these plays are; 1 being the lowest and 5 is the highest.


Follow me on Social Media!




Webull Account-4 Free Stocks with a chance to get $FB Facebook


Disclaimer: The comments opinions and analysis expressed herein are for informational and educational purpose only and should not be considered as individual advice or recommendations. is not responsible or liable in any way for opinions expressed here. This is not meant to be financial advice as we are not a licensed financial advisor.

1,034 views0 comments

Recent Posts

See All